Stem Cell Blog

Употребата на матичните клетки од папочна врвца рапидно се зголемува. Пред 10 години крвта од папочна врвца можеше да лекува околу 40 состојби, но денес таа бројка е над 80. Со нетрпение очекуваме нови терапии за болести и нарушувања како што се дијабет, аутизам и мозочен удар, можете да бидете во тек со најновите случувања во регенеративната медицина на нашиот блог за матични клетки.



US-hospital-placenta-therapy-covid-19.png

A US hospital has become the first hospital in the nation to use a placenta-based cell-therapy to treat COVID-19 patients, which has resulted in the coronavirus-recovered patients heading home.

Holy name is the first in the US to use the latest placenta-based cell-therapy from Pluristem. The treatment uses cells from the placenta which is then injected into the arms and legs of the patient. A 49-year-old COVID-19 patient on a ventilator, was one of the first patients without organ failure to receive the placenta cell treatment.


30-years-of-cord-blood-banking.jpg

In 1988, an international team of doctors came together to perform the first ever cord blood transplant on a five-year-old boy. On the 30th anniversary of his surgery, Cells4Life takes a look at the past, present and future of stem cell science.

30 years ago, regenerative medicine was in its nascent stages. The possibility of re-growing organs or treating diseases and disorders like stroke and cancer was the stuff of science fiction.


world_cord_blood_day_blog.jpg

Parents, doctors, nurses and midwives are encouraged to learn more about cord blood stem cells this week as the second ever World Cord Blood Day 2018 takes place.

The initiative includes talks and workshops across the globe. They are intended to promote cord blood therapy, including a virtual webinar featuring leading researchers and industry experts.


shutterstock_1620672310-980x700-1.jpg

The World Health Organisation (WHO) has declared Coronavirus (aka COVID-19) a “public health emergency of international concern”. With the number of cases continuing to increase and no vaccine or specific antiviral treatment currently available, finding a safe and effective therapeutic approach to treat patients infected with the virus has become priority.